First-in-human study of GFH018, a small molecule inhibitor of transforming growth factor-β receptor I inhibitor, in patients with advanced solid tumors.
Guo Y, Wang Z, Zhou H, Pan H, Han W, Deng Y, Li Q, Xue J, Ge X, Wang S, Wang J, Zhang Y, Zhao C, Zhu H, Wang Y, Shen H, Liu D, Li J.
Guo Y, et al. Among authors: wang z, wang j, wang y, wang s.
BMC Cancer. 2024 Apr 10;24(1):444. doi: 10.1186/s12885-024-12216-7.
BMC Cancer. 2024.
PMID: 38600507
Free PMC article.